Insider Ownership Filing for Yew Chak Hua

This filing details the initial ownership of securities by Yew Chak Hua, who is a director at CytoMed Therapeutics Ltd. The filing indicates that Mr. Hua directly owns 2469 ordinary shares following a transaction. The reporting of this ownership is in accordance with SEC regulations for insider transactions. The issuer is CytoMed Therapeutics Ltd, trading under the symbol GDTC.